The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

In Europe, meanwhile, Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) is indicated as a second-line therapy for recurrent or advanced cervical cancer, regardless of PD-L1 expression status, ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer. The BELLA phase 2 clinical trial of relacorilant plus ...

The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV. The test will first be available in ...

The FDA just approved a tampon-like device that lets you collect your own sample for cervical cancer screening.

For the first time, the FDA has just approved a device that lets people screen for cervical cancer from home. Known as the ...

Teal Health, the maker of an at-home cervical cancer screening test, says it will give patients an alternative to in-clinic pap smears.

There's a new self-guided way to screen for cervical cancer at home that was approved by the FDA. But doctors caution that it ...

The U.S. Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal ...

Indigenously developed (Human papillomavirus) HPV test kits for cervical cancer screening were launched on Wednesday (April 23, 2025). The test kits have been developed under the Department of ...

In clinical trials, the accuracy of self-testing with Teal’s wand matched that of a cancer screening performed in a doctor’s ...

Led by the Cebu City Health Department, DOH Region 7, and Jhpiego Philippines, the campaign aims to expand cervical cancer ...